HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joan Genescà Selected Research
Joan Genescà Research Topics
Disease
24
Fibrosis (Cirrhosis)
02/2024 - 01/2005
17
Hemorrhage
10/2023 - 06/2003
14
Liver Diseases (Liver Disease)
10/2023 - 05/2004
12
Portal Hypertension
01/2023 - 07/2008
11
Infections
01/2022 - 05/2004
10
Liver Cirrhosis (Hepatic Cirrhosis)
10/2023 - 01/2002
6
Hepatic Encephalopathy
10/2021 - 03/2017
6
Chronic Hepatitis C
01/2021 - 11/2004
5
Hepatocellular Carcinoma (Hepatoma)
01/2020 - 12/2009
4
Non-alcoholic Fatty Liver Disease
11/2023 - 05/2018
4
End Stage Liver Disease
01/2022 - 01/2016
4
Ascites
12/2021 - 01/2019
3
Bacterial Infections (Bacterial Infection)
01/2022 - 12/2009
3
Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2006
3
Varicose Veins (Varicose Vein)
04/2019 - 06/2003
2
Hepatitis C
04/2022 - 01/2020
2
Liver Neoplasms (Liver Cancer)
04/2022 - 01/2020
2
Alcoholic Hepatitis
01/2022 - 12/2019
2
Atrophy
01/2014 - 09/2012
2
Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
08/2012 - 10/2006
2
Peritonitis
09/2008 - 01/2002
2
Virus Diseases (Viral Diseases)
11/2006 - 11/2004
2
Chronic Hepatitis (Chronic Active Hepatitis)
11/2004 - 05/2004
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1
Hyponatremia
10/2023
1
Hyperbilirubinemia
01/2023
1
Rare Diseases (Rare Disease)
01/2023
1
Acute-On-Chronic Liver Failure
01/2022
1
Inborn Genetic Diseases (Disease, Hereditary)
09/2021
1
Alcoholic Fatty Liver
01/2021
1
Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2021
1
Chronic Hepatitis B
01/2021
1
Necrosis
01/2020
1
Dyspnea (Shortness of Breath)
01/2020
1
Adenoma (Adenomas)
01/2020
1
Hepatopulmonary Syndrome
01/2020
1
Myocardial Infarction
01/2019
1
Morbid Obesity
05/2018
1
Weight Loss (Weight Reduction)
05/2018
1
Disease Susceptibility (Diathesis)
10/2017
1
Vascular Diseases (Vascular Disease)
10/2017
1
Disease Progression
03/2017
Drug/Important Bio-Agent (IBA)
7
Glucose (Dextrose)
FDA Link
Generic
07/2023 - 05/2004
6
Antiviral Agents (Antivirals)
IBA
02/2024 - 11/2006
6
Creatinine
IBA
10/2023 - 12/2009
4
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
10/2023 - 01/2017
4
4-(3-chlorophenylsulfanyl)piperidine
IBA
01/2023 - 01/2016
4
Albumins
IBA
04/2022 - 10/2009
3
Simvastatin (Zocor)
FDA Link
Generic
10/2023 - 01/2017
3
Proteins (Proteins, Gene)
FDA Link
07/2023 - 04/2010
3
Anti-Bacterial Agents (Antibiotics)
IBA
01/2018 - 10/2011
3
Adrenergic Agents (Adrenergic Drugs)
IBA
01/2014 - 07/2008
2
Sodium
IBA
10/2023 - 01/2022
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
10/2023 - 01/2021
2
Micelles
IBA
10/2023 - 10/2020
2
Carbon Tetrachloride (Tetrachloromethane)
IBA
07/2023 - 01/2017
2
Interferons
IBA
04/2022 - 10/2007
2
Polymers
IBA
11/2021 - 09/2021
2
Ammonia
IBA
03/2017 - 11/2016
2
Propranolol (Inderal)
FDA Link
Generic
01/2016 - 06/2003
2
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
10/2011 - 07/2010
2
Norfloxacin
FDA Link
09/2008 - 01/2002
2
Quinolones
IBA
09/2008 - 01/2002
2
Cytokines
IBA
05/2006 - 04/2004
1
Cytidine Triphosphate (CTP)
IBA
10/2023
1
Thioacetamide (Thioacetamid)
IBA
10/2023
1
Collagen
IBA
10/2023
1
Fructose
IBA
07/2023
1
Insulin (Novolin)
FDA Link
05/2022
1
Telmisartan (Micardis)
FDA Link
05/2022
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
04/2022
1
Fetal Proteins (Fetoprotein)
IBA
04/2022
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
01/2022
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2022
1
Rifaximin (L 105)
FDA Link
01/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022
1
MicroRNAs (MicroRNA)
IBA
12/2021
1
Biomarkers (Surrogate Marker)
IBA
12/2021
1
Enzymes
IBA
01/2021
1
Endothelin-1 (Endothelin 1)
IBA
01/2021
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2020
1
theasinensin A
IBA
01/2020
1
Prednisolone (Predate)
FDA Link
Generic
12/2019
1
Calcium
IBA
01/2019
1
Lipopolysaccharides
IBA
03/2017
1
ammonium acetate
IBA
03/2017
1
Platelet Endothelial Cell Adhesion Molecule-1
IBA
01/2017
1
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
01/2017
Therapy/Procedure
17
Therapeutics
02/2024 - 10/2006
10
Surgical Portasystemic Shunt (Portosystemic Shunt)
02/2024 - 07/2010
7
Liver Transplantation
01/2023 - 01/2005
5
Ligation
10/2023 - 10/2011
4
Transjugular Intrahepatic Portasystemic Shunt
10/2023 - 10/2006
3
Antibiotic Prophylaxis
01/2021 - 07/2010
2
Drug Therapy (Chemotherapy)
08/2012 - 06/2003
1
Glycemic Control
11/2023
1
Contraindications
10/2023
1
Aftercare (After-Treatment)
01/2020
1
Bariatric Surgery
05/2018
1
Surgical Portacaval Shunt (Portacaval Anastomosis)
03/2017